Thrivent Financial for Lutherans Buys 111,169 Shares of iShares Biotechnology ETF $IBB

Thrivent Financial for Lutherans raised its stake in iShares Biotechnology ETF (NASDAQ:IBB) by 99.4% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 223,032 shares of the financial services provider’s stock after acquiring an additional 111,169 shares during the quarter. Thrivent Financial for Lutherans owned about 0.45% of iShares Biotechnology ETF worth $37,641,000 at the end of the most recent reporting period.

Several other large investors have also recently bought and sold shares of IBB. Allspring Global Investments Holdings LLC increased its holdings in shares of iShares Biotechnology ETF by 46,806.0% during the fourth quarter. Allspring Global Investments Holdings LLC now owns 46,906 shares of the financial services provider’s stock worth $7,927,000 after purchasing an additional 46,806 shares during the period. Aster Capital Management DIFC Ltd bought a new position in shares of iShares Biotechnology ETF during the third quarter worth approximately $1,907,000. Central Pacific Bank Trust Division increased its holdings in shares of iShares Biotechnology ETF by 296,500.0% during the fourth quarter. Central Pacific Bank Trust Division now owns 14,830 shares of the financial services provider’s stock worth $2,503,000 after purchasing an additional 14,825 shares during the period. Florin Court Capital LLP bought a new position in shares of iShares Biotechnology ETF during the third quarter worth approximately $11,116,000. Finally, Tudor Investment Corp ET AL bought a new position in shares of iShares Biotechnology ETF during the third quarter worth approximately $931,000. 62.45% of the stock is owned by institutional investors.

iShares Biotechnology ETF Stock Down 2.6%

Shares of IBB opened at $166.83 on Friday. iShares Biotechnology ETF has a 12 month low of $118.51 and a 12 month high of $179.64. The firm’s 50 day moving average is $169.24 and its 200-day moving average is $169.57.

iShares Biotechnology ETF Cuts Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, March 20th. Stockholders of record on Tuesday, March 17th were issued a dividend of $0.1218 per share. The ex-dividend date of this dividend was Tuesday, March 17th. This represents a $0.49 annualized dividend and a dividend yield of 0.3%.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.